SENSEX: 72,400 ▲ 0.5% NIFTY: 21,800 ▲ 0.4% GOLD: 62,500 ▼ 0.2%

US FDA clearance

Glenmark Pharmaceuticals Q3 FY26 Revenue Rises 15.1% on Strong Domestic and North American Growth

● Feb 2, 2026

Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) reported consolidated revenue of ₹39,006 million for the third quarter ended December 31, 2025, a...

Glenmark Rallies as Q3 Margins Expand, FDA Clears U.S. Facility

● Feb 2, 2026

Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) The Mumbai-based pharmaceutical company posts strong domestic and international sales as it transitions toward an...

Market Headlines

Trump family crypto firm sold major stake to UAE investment firm - The Washington Post 02 Feb, 04:04
Bitcoin holds below $80,000 as January prediction contracts miss liquidation-driven slide: Asia Morning Briefing - CoinDesk 02 Feb, 02:38
Price of consumer goods could surge as shipping costs soar, industry body says - The Guardian 02 Feb, 02:30
Nvidia’s not investing $100 billion in OpenAI because the chip designer doesn’t want to pay the OpenAI valuation tax - Sherwood News 02 Feb, 01:52
Oracle to Raise Up to $50 Billion This Year for Cloud Investment - Bloomberg.com 02 Feb, 01:50

AlphaStreet Newsletter

Get the latest market analysis delivered to your inbox.